Wellington Management

News, insights, analysis and data

← Back to Wellington Management profile

Wellington Management related stories

All articles and analysis

  • DocuSign racks up $233 mln
    Iris Dorbian- 12 May 2015

    Electronic signature company DocuSign has secured $233 million in funding. Brookside Capital and Bain Capital Ventures led the round.

  • VC-backed Adaptimmune rolls out IPO
    Iris Dorbian- 6 May 2015

    UK and Philadelphia-based biotechnology company Adaptimmune Therapeutics plc has debuted its IPO after pricing its 11.25 million shares at $17 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol "ADAP." BofA Merrill Lynch, Cowen and Company and Leerink Partners LLC are serving as the lead underwriters. Adaptimmune's backers include New Enterprise Associates, OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management and Rock Springs Capital.

  • Jobs of the week: Wellington, Pegasus Capital, Citi and Bainbridge are hiring
    Iris Dorbian- 27 April 2015

    This week's job opportunities include a private equity director at Zurich Alternative Asset and a managing director at Hercules Technology Growth Capital. Plus, Wellington is seeking a private equity principal at Wellington while Citi is looking for a private equity funds VP.

  • Data storage company Nutanix to hire banks for IPO - Reuters
    Luisa Beltran- 27 April 2015

    Nutanix, a maker of server and storage systems, is in talks to hire underwriters for an initial public offering later this year that could value the U.S. company at more than $2.5 billion, including debt, sources told Reuters News.

  • Jounce Therapeutics picks up $56 mln Series B
    Iris Dorbian- 23 April 2015

    Cambridge, Massachusetts-based Jounce Therapeutics, which is focused on discovering and developing cancer immunotherapies, has closed $56 million in Series B funding. The investors included Wellington Management Company, Redmile Group, Nextech Invest, Pharmstandard International, S.A., Cormorant Asset Management, Omega Funds, Casdin Capital and Foresite Capital Management.

  • Health insurer Oscar raises $145 million in new financing-Reuters
    Reuters News- 21 April 2015

    Oscar Health Insurance, a privately held company that aims to shake up the industry with technology-driven services for individual consumers, on Monday said it had secured $145 million in new funding led by technology investor Peter Thiel.

  • Data storage startup Pure Storage taps banks for IPO - Reuters
    Reuters News- 7 April 2015

    Pure Storage Inc is making preparations for an initial public offering, including hiring underwriters, one year after a private placement valued the data storage company at more than $3 billion, Reuters News reported.

  • Zuora attracts $115 mln from Wellington, BlackRock, Passport, others
    Mark Boslet- 11 March 2015

    Zuora said it raised a $115 million Series F round of financing in a deal that brought in new investors Wellington Management Company, BlackRock, Premji and Passport Capital. Existing investors Benchmark Capital, Greylock Capital, Redpoint Ventures, Index Ventures, Shasta Ventures, Vulcan Capital, Next World Capital, Workday co-founder Dave Duffield and Salesforce CEO Marc Benioff joined the round.

  • Global Blood Therapeutics rakes in $48 mln Series B
    Iris Dorbian- 6 January 2015

    South San Francisco, Calif.-based Global Blood Therapeutics, a biopharmaceutical firm that focuses on treating severe blood disorders, has raised $48 million in Series B funding. The investors included Wellington Management Company, RA Capital, Deerfield Management, Sabby Capital and Perceptive Life Sciences.

  • Moderna Therapeutics scores $450 mln
    Iris Dorbian- 6 January 2015

    Cambridge Mass.-based biotech firm Moderna Therapeutics has closed $450 million in funding. The backers in this round include Viking Global Investors, Invus, RA Capital Management, Wellington Management Company, AstraZeneca and Alexion Pharmaceuticals.